LATEST

Off the Wire

IN FOCUS

Second Chances at a Price: The High Stakes of Reoperation in Breast Cancer

A recent study published in the Annals of Surgical Oncology, has brought attention to a concerning trend in the treatment of breast cancer, specifically regarding breast-conserving surgery....

Nanotechnology-Enhanced Resveratrol Shows Promise in Treatment of Triple-Negative Breast Cancer

Yes, it's that kind of resveratrol--that found in red wine. But with a technical twist to ensure it's delivered properly. Triple-negative breast cancer (TNBC) is a type of...

Study Examines Hyperbaric Oxygen Therapy for Breast Cancer Patients

Hyperbaric Oxygen Therapy (HBOT) is a medical treatment that involves breathing pure oxygen in a pressurized room or chamber. In these hyperbaric (high pressure) conditions, your lungs...

LEARN MORE

RESEARCH

RESEARCH

LEARN MORE

Talimogene Laherparepvec in HER2-Negative Breast Cancer: A Phase Ib Study

A new clinical study at the National Cancer Institute in the U.S. is looking into a treatment method for patients with a specific type...

Advancements in HER2-Positive Breast Cancer: New Treatments Promise Improved Survival

Today we wanted to point to an outstanding interview with Dr. Nicholas P. McAndrew, an expert in breast cancer treatment. He recently shared insights on...

AMA Introduces New CPT Code for Seno Medical’s Breast Imaging Technology

The American Medical Association (AMA) has recently introduced a new Current Procedural Terminology (CPT) code, specifically for the Imagio Breast Imaging System developed by...

New Strategies and Tech in Lymphedema Prevention Following Breast Cancer

Developing effective strategies for preventing breast cancer-related arm lymphedema (BCRAL) remains a significant unmet need in healthcare, as there are currently no effective treatments...

Omega-3 Fatty Acid and Breast Cancer Prevention for Patients Hoping for Pregnancy

A pilot trial at the National Cancer Institute, conducted by the University of Kansas Cancer Center and led by Principal Investigator Lauren Nye aims...

DRUG DEVELOPMENT